Kenji Kashiwagi

Title: Kenji Kashiwagi: Innovator in Peptide Synthesis

Introduction

Kenji Kashiwagi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of peptide synthesis, particularly through his innovative patent that enhances the efficiency of translational synthesis.

Latest Patents

Kashiwagi holds a patent titled "Rapid display method in translational synthesis of peptide." This invention provides linkers that are suitable for preparing a conjugate of a nucleic acid and a peptide as a translation product in a reconstituted cell-free translation system. The linkers feature a single-stranded structure region that pairs with the base at the 3′-end of an mRNA and a peptidyl acceptor region containing an amino acid attached to an oligo RNA via an ester bond. Notably, the ester bond is formed using an artificial RNA catalyst, which is a key aspect of his invention. The patent also includes display methods utilizing [mRNA]-[linker]-[peptide] conjugates assembled through these linkers.

Career Highlights

Kashiwagi is associated with Peptidream Inc., a company that focuses on peptide-based drug discovery and development. His work at Peptidream has allowed him to explore innovative approaches in peptide synthesis and contribute to advancements in the field.

Collaborations

Throughout his career, Kenji Kashiwagi has collaborated with notable colleagues, including Patrick Reid and C Patrick Reid. These collaborations have further enriched his research and development efforts in peptide synthesis.

Conclusion

Kenji Kashiwagi's contributions to peptide synthesis through his innovative patent demonstrate his expertise and commitment to advancing the field. His work continues to influence the development of new methodologies in translational synthesis.